Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2020
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
Lisa R Sammaritano, Bonnie L Bermas, Eliza E Chakravarty, et al.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
Best Practice & Research. Clinical Rheumatology
|
September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc
Lesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Rheumatology (Oxford, England)
|
September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Annals of the Rheumatic Diseases
|
February 5, 2026
Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis
Urvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2020
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
Lisa R Sammaritano, Bonnie L Bermas, Eliza E Chakravarty, et al.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
Best Practice & Research. Clinical Rheumatology
|
September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc
Lesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Rheumatology (Oxford, England)
|
September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Annals of the Rheumatic Diseases
|
February 5, 2026
Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis
Urvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, et al.
Page
of 9